Report on China’s Veterinary Biologics Industry Investment

By CnAgri 2016-01-06 15:38:42 Print Tel:861064402035 Email: [email protected]

Price: (English Version) (Chinese Version)

Brief Introduction:

Basic Information:

Table of Contents:

Table of Contents
1. Development Course and Direction of China’s Veterinary Biologics Industry.......................... 1
1.1 China’s Veterinary Biological Industry Development Course.......................................... 1
1.2 Position and Market Share of Biological Products in China’s Veterinary Heath-care Industry       2
1.3 Comparison between Global and China’s Veterinary Biologics Industry......................... 3
1.4 China’s Veterinary Biologics Industry Development Direction......................................... 5
2 Policy Environment of China’s Veterinary Biologics Industry.................................................... 8
2.1 Production Policy for China’s Veterinary Biologic Industry............................................. 8
2.2 Planning of China’s Veterinary Biologic Industry........................................................... 11
2.3 Impact of Compulsory Immunization Policy on China’s Veterinary Biologic Industry..... 12
2.4 Trade Policy for China’s Veterinary Biologic Industry................................................... 13
2.5 Circulation Policy for China’s Veterinary Biologic Industry............................................ 14
2.6 Impact of China’s Veterinary Biologic Industry Policy on Future Industry Development 15
3 Market Scale and Development Trend of China’s Veterinary Biologics Industry..................... 16
3.1 Scale of China’s Veterinary Biological Products by Types............................................ 16
3.1.1Market Scale of Compulsory Immunization Vaccine............................................. 16
3.1.2 Market Scale of Domestic-produced Conventional Vaccine................................ 17
3.1.3Market Scale of Imported Conventional Vaccine................................................. 17
3.2 China’s Hog Biological Products Market Scale and Estimation...................................... 19
3.2.1 Occurrence of Hog Diseases and Development Trend in China........................ 19
3.2.2 Status quo of China’s Hog Biological Products Utility and Market Demand......... 21
3.2.3 Major Products and Market Share of China’s Hog Biological Products............... 21
3.2.4 Estimation of China’s Hog Biological Products Market Growth........................... 22
3.3 China’s Poultry Biological Products Market Scale and Estimation................................. 23
3.3.1 Occurrence of Poultry Diseases and Development Trend in China.................... 23
3.3.2 Status quo of China’s Poultry Biological Products Utility and Market Demand.... 25
3.3.3 Major Products and Market Share of China’s Poultry Biological Products.......... 25
3.3.4Estimation of China’s Poultry Biological Products Market Growth........................ 26
3.4 China’s Ruminant Veterinary Biological Products Market Scale and Estimation............. 27
3.4.1 Occurrence of Ruminant Animal Diseases and Development Trend in China..... 27
3.4.2 Status quo of China’s Ruminant Veterinary Biological Products Utility and Market Demand      29
3.4.3 Major Products and Market Share of China’s Ruminant Veterinary Biological Products      29
3.4.4Estimation of China’s Ruminant Veterinary Biological Products Market Growth... 30
3.5 China’s Aquatic Veterinary Biological Products Market Scale and Estimation................ 30
3.5.1 Occurrence of Aquatic Animal Diseases and Development Trend in China......... 30
3.5.2 Status quo of China’s Aquatic Veterinary Biological Products Utility and Market Demand   31
3.5.3 Major Products and Market Share of China’s Aquatic Veterinary Biological Products  31
3.5.4Estimation of China’s Aquatic Veterinary Biological Products Market Growth....... 31
3.6 China’s Pet Veterinary Biological Products Market Scale and Estimation...................... 32
3.6.1 Occurrence of Pet Animal Diseases and Development Trend in China............... 32
3.6.2 Status quo of China’s Pet Veterinary Biological Products Utility and Market Demand  33
3.6.3 Major Products and Market Share of China’s Pet Veterinary Biological Products 33
4 Analysis of China’s Veterinary Biologics Industry Chain.......................................................... 35
4.1 Research and Development (R&D).............................................................................. 35
4.1.1 Major Research Institutions of Veterinary Biological Products in China.............. 35
4.1.2 Technical R&D Capability of China’s Veterinary Biologics Industry..................... 36
4.1.3 Mechanism of Technical R&D Investment in Veterinary Biologics Industry in China... 36
4.2 Production................................................................................................................... 39
4.2.1 Output Capacity and Output Value of China’s Veterinary Biological Products Market  39
4.2.2 Production Profit of China’s Veterinary Biologics Industry.................................. 40
4.2.3 Price Trend of China’s Major Veterinary Biological Products.............................. 41
4.2.3.1 Price Trend of China’s Major Hog Veterinary Biological Products.......................................... 41
4.2.3.2 Price Trend of China’s Major Poultry Veterinary Biological Products..................................... 42
4.2.4 Structure and Locations of China’s Major Veterinary Biologics Enterprises........ 43
4.2.5 Concentration of China’s Veterinary Biological Products Market........................ 45
4.3 Circulation.................................................................................................................... 46
4.3.1Circulation Pattern of China’s Veterinary Biological Products.............................. 46
4.3.2 Analysis of Marketing Channels of China’s Veterinary Biological Products......... 47
4.3.3 Analysis of Profit Distribution in China’s Veterinary Biological Products Circulation 48
4.3.3.1 The Marketing Pattern and Cost Structure of the Level 1 Distributor...................................... 48
4.3.3.2 The Marketing Pattern and Cost Structure of Level 2 Distributor............................................. 49
4.3.3.3 The Marketing Pattern and Cost Structure of Direct Distributor............................................... 50
4.3.3.4 Analysis of Profit Distribution among Distributors at Different Levels.................................... 51
4.3.4 Major Marketing Patterns and Customer Strategies of China’s Veterinary Biological Products  52
4.3.5 The Impact of GSP on the Circulation and Marketing of China’s Veterinary Biological Products      53
4.4 Overall Evaluation of China’s Veterinary Biologics Industry Chain................................ 53
5 Analysis of Investment Opportunities and Directions in China’s Veterinary Biologics Industry 55
5.1 Analysis of Investment Opportunities and Directions in China’s Hog Veterinary Biological Products   55
5.2 Analysis of Investment Opportunities and Directions in China’s Poultry Veterinary Biological Products      58
5.3 Analysis of Investment Opportunities and Directions in China’s Ruminant Veterinary Biological Products  61
5.4 Analysis of Investment Opportunities and Direction sin China’s Aquatic Veterinary Biological Products     61
5.5 Analysis of Investment Opportunities and Directions in China’s Pet Veterinary Biological Products    62
5.6 Analysis of Investment Opportunities and Directions in China’s Other Veterinary Biological Products 62
6 Analysis of the Investment Risks in China’s Veterinary Biologics Industry.............................. 63
6.1 Risk of Low R&D Capability.......................................................................................... 63
6.2 Risk of Intellectual Property Protection........................................................................ 63
6.3 Risk of Products Quality Control.................................................................................. 64
6.4 Risk of Severe Animal Diseases................................................................................... 65
6.5 Risk of Shortage of Service Capability and Human Resources.................................... 65
6.6 Risk of Market Competition.......................................................................................... 66
7 Analysis of Key Enterprises in China’s Veterinary Biologics Industry...................................... 67
7.1 Analysis of Listed Enterprises...................................................................................... 67
7.1.1 CAHIC (China Animal Husbandry Industry Co., Ltd)........................................... 67
7.1.1.1 Enterprise Profile.............................................................................................................................. 67
7.1.1.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio............................................ 67
7.1.1.3 Sales Revenue, Profit and Trend of Share Prices...................................................................... 67
7.1.1.4 Constitution of Major Business/ Products/Service...................................................................... 68
7.1.2 TCSW................................................................................................................ 69
7.1.2.1 Enterprise Profile.............................................................................................................................. 69
7.1.2.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio............................................ 69
7.1.2.3 Sales Revenue, Profit and Trend of Share Prices...................................................................... 70
7.1.2.4 Sales Revenue, Profit and Trend of Share Prices...................................................................... 70
7.1.3 Inner Mongolia Jinyu Group Co., Ltd................................................................. 71
7.1.3.1 Enterprise Profile.............................................................................................................................. 71
7.1.3.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio............................................ 72
7.1.3.3 Sales Revenue, Profit and Trend of Share Prices...................................................................... 72
7.1.3.4 Constitution of Major Business/ Products/Service...................................................................... 72
7.1.4 Ringpu Biology................................................................................................... 73
7.1.4.1 Enterprise Profile.............................................................................................................................. 73
7.1.4.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio............................................ 73
7.1.4.3 Sales Revenue, Profit and Trend of Share Prices...................................................................... 74
7.1.4.4 Constitution of Major Business/ Products/Service...................................................................... 74
7.2 Analysis of Enterprises not listed................................................................................. 75
7.2.1 Analysis of China’s Top 10 Hog Veterinary Biological Products Enterprises....... 75
7.2.2 Analysis of China’s Top 10 Poultry Veterinary Biological Products Enterprises... 76
7.3 Selection and Analysis of China’s Other Veterinary Biological Products Enterprises.... 77
8 Major Foreign-Invested Enterprises and Analysis of Their Market Competitiveness.............. 78
8.1 Pfizer/ Fort Dodge....................................................................................................... 78
8.1.1 Profile of China Branch...................................................................................... 78
8.1.2 Sales Revenue................................................................................................... 79
8.1.3 Major Products and Market Share...................................................................... 79
8.1.4 Analysis of Its Competitiveness in Chinese Market............................................ 79
8.2 Boehringer Ingelheim................................................................................................... 79
8.2.1 Profile of China Branch...................................................................................... 79
8.2.2 Sales Revenue................................................................................................... 80
8.2.3 Major Products and Market Share...................................................................... 80
8.2.4 Analysis of Its Competitiveness in Chinese Market............................................ 80
8.3 Merial........................................................................................................................... 80
8.3.1 Profile of China Branch...................................................................................... 80
8.3.2 Sales Revenue................................................................................................... 81
8.3.3 Major Products and Market Share...................................................................... 81
8.3.4 Analysis of Its Competitiveness in Chinese Market............................................ 82
8.4 Bayer........................................................................................................................... 82
8.4.1 Profile of China Branch...................................................................................... 82
8.4.2 Sales Revenue................................................................................................... 82
8.4.3 Major Products and Market Share...................................................................... 82
8.4.4 Analysis of Its Competitiveness in Chinese Market............................................ 83
8.5 Novartis........................................................................................................................ 83
8.5.1 Profile of China Branch...................................................................................... 83
8.5.2 Sales Revenue................................................................................................... 83
8.5.3 Major Products and Market Share...................................................................... 83
8.5.4Analysis of Its Competitiveness in Chinese Market............................................. 84
8.6 Hipra............................................................................................................................ 84
8.6.1 Profile of China Branch...................................................................................... 84
8.6.2 Sales Revenue................................................................................................... 84
8.6.3 Major Products and Market Share...................................................................... 84
8.6.4 Analysis of Its Competitiveness in Chinese Market............................................ 85
8.7 Intervet / Schering-Plough........................................................................................... 85
8.7.1 Profile of China Branch...................................................................................... 85
8.7.2 Sales Revenue................................................................................................... 85
8.7.3 Major Products and Market Share...................................................................... 86
8.7.4 Analysis of Its Competitiveness in Chinese Market............................................ 86
8.8 Lohmann...................................................................................................................... 87
8.8.1 Profile of China Branch...................................................................................... 87
8.8.2 Sales Revenue................................................................................................... 87
8.8.3 Major Products and Market Share...................................................................... 87
8.8.4 Analysis of Its Competitiveness in Chinese Market............................................ 88
8.9 U.S. PeproTech............................................................................................................ 88
8.9.1 Profile of China Branch...................................................................................... 88
8.9.2 Sales Revenue................................................................................................... 88
8.9.3 Major Products and Market Share...................................................................... 89
8.9.4 Analysis of Its Competitiveness in Chinese Market............................................ 89
8.10 Italy Ascor Chimici Srl................................................................................................. 89
8.10.1 Profile of China Branch.................................................................................... 89
8.10.2 Sales Revenue................................................................................................. 89
8.10.3 Major Products and Market Share.................................................................... 89
8.10.4 Analysis of Its Competitiveness in Chinese Market.......................................... 90
Appendix:Name List of China’s Veterinary Biological Products Enterprises............................... 91
 

Explore Realted News »
Explore Realted Reports »